SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1233COMPANIES & FINANCE THE AMERICAS: Pfizer R&D unable to sustain group groIcebrg-12/17/2001
1232Amgen Nears a Deal to Buy Immunex; [WSJ] Pact Could Inspire More Consolidation Doc Bones-12/17/2001
1231Feuerstein earlier that day had mocked rumors of the AMGN-IMNX deal. Note that Doc Bones-12/17/2001
1230<<What are your valuation metrics?>> Before rumor on IMNX deal AMGNMiljenko Zuanic-12/16/2001
1229<i>It is AMGN who is ballooned</i> Ballooned as in a bubble, but a Sam Citron-12/16/2001
1228>> "Before the first data ever came out on Enbrel, AHP made an offer scaram(o)uche-12/16/2001
1227In Immunex, Amgen Sees a Prize Friday, December 14, 2001 By Justin Gillis, Wassim1-12/16/2001
1226Biotech Merger Trend Speeds Up During 'Hunting Season' By VICTORIA MARCIcebrg-12/15/2001
1225The Prescription Is Merger Biotech Firms Stock Their Medicine Chests by Snappinsim1-12/15/2001
1224<<"OK, I can't find anyone who thinks the rumored Amgen-Immunex dMiljenko Zuanic-12/14/2001
1223I've actually always though IMNX/BGEN made sense - solve the short-term EnbrBiomaven-12/14/2001
1222Adam Feuerstein on realmoney.com writes that his hedgie sources contend BGEN wouMichael Young-12/14/2001
1221<i>why on earth would AHP sell at this price?</i> AHP may be savvy Biomaven-12/14/2001
1220Or why on earth would AHP sell at this price?mopgcw-12/14/2001
1219My view is that price is too low. IMNX isn't only Enbrel. The bigger surprisMiljenko Zuanic-12/13/2001
1218Amgen Discusses Acquisition of Immunex in Possible $17 Billion Deal -DBiomaven-12/13/2001
1217John, Levin also adds capable and experienced scientists to his staff that have Mark Bong-12/12/2001
1216"Mr. Levin said biotechnology companies seemed to realize now that not all John Metcalf-12/11/2001
1215An AP article does a similar rehash of biotech hunters/huntees, but mentions somtuck-12/11/2001
1214I suspect it doesn't mean <i>approved</i> products. Plenty of thnigel bates-12/7/2001
1213Here's a Reuter's piece predicting a feeding frenzy of sorts. I'd liBiomaven-12/7/2001
1212<i>"Preyed" is sort of a strong word.</i> Hey - just tryiBiomaven-12/7/2001
1211Peter, I agree that it is clear that there is good logic to this merger. In the Mark Bong-12/7/2001
1210Mark, This article kind of fits with my current (somewhat revised) view of the Biomaven-12/7/2001
1209The following NYT article adds a little color to the reasons why MLNM did the meMark Bong-12/7/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News